Marras TK - Search Results

1

Applying a prediction rule to identify low-risk patients with community-acquired pneumonia.

Marras TK, Gutierrez C, Chan CK. Marras TK, et al. Chest. 2000 Nov;118(5):1339-43. doi: 10.1378/chest.118.5.1339. Chest. 2000. PMID: 11083684

2

Use of guidelines in treating community-acquired pneumonia.

Marras TK, Chan CK. Marras TK, et al. Chest. 1998 Jun;113(6):1689-94. doi: 10.1378/chest.113.6.1689. Chest. 1998. PMID: 9631814

3

Antibiotic guidelines for pneumonia in chronic-care facilities.

Marras TK, Chan CK. Marras TK, et al. Clin Invest Med. 2002 Jun;25(3):63-4; author reply 64. Clin Invest Med. 2002. PMID: 12137250 No abstract available.

4

Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.

Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK. Marras TK, et al. Transpl Infect Dis. 2002 Jun;4(2):66-74. doi: 10.1034/j.1399-3062.2002.t01-1-00008.x. Transpl Infect Dis. 2002. PMID: 12220242

5

Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument.

Marras TK, Szalai JP, Chan CK, Lipton JH, Messner HA, Laupacis A. Marras TK, et al. Bone Marrow Transplant. 2002 Nov;30(9):599-607. doi: 10.1038/sj.bmt.1703700. Bone Marrow Transplant. 2002. PMID: 12407435

6

Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000.

Marras TK, Wilson J, Wang EE, Avendano M, Yang JW. Marras TK, et al. Chest. 2003 Sep;124(3):915-21. doi: 10.1378/chest.124.3.915. Chest. 2003. PMID: 12970017

7

Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation.

Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A. Marras TK, et al. Bone Marrow Transplant. 2004 Mar;33(5):509-17. doi: 10.1038/sj.bmt.1704377. Bone Marrow Transplant. 2004. PMID: 14716347

8

Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.

Marras TK, Nopmaneejumruslers C, Chan CK. Marras TK, et al. Am J Med. 2004 Mar 15;116(6):385-93. doi: 10.1016/j.amjmed.2003.11.013. Am J Med. 2004. PMID: 15006587

9

Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals.

Marras TK, Jamieson L, Chan CK. Marras TK, et al. Can Respir J. 2004 Mar;11(2):131-7. doi: 10.1155/2004/970828. Can Respir J. 2004. PMID: 15045044 Free article.

10

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).

Noreddin AM, Marras TK, Sanders K, Chan CK, Hoban DJ, Zhanel GG. Noreddin AM, et al. Among authors: marras tk. Int J Antimicrob Agents. 2004 Nov;24(5):479-84. doi: 10.1016/j.ijantimicag.2004.06.010. Int J Antimicrob Agents. 2004. PMID: 15519481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters